Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2010
10/21/2010US20100267611 Treatment of metabolic disease
10/21/2010US20100267610 Polypeptide comprising a knottin protein moiety
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/21/2010US20100267608 Modifications of cupredoxin derived peptides and methods of use thereof
10/21/2010US20100267140 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/21/2010US20100267084 Protein glycosylation modification in methylotrophic yeast
10/21/2010US20100267046 Isoform-selective inhibitor and activators of pde3 cyclic nucleotide phosphodiesterases
10/21/2010US20100267027 Her-2 binding antagonists
10/21/2010US20100266704 Octreotide depot formulation with constantly high exposure levels
10/21/2010US20100266698 Use of insulin for the treatment of cartilaginous disorders
10/21/2010US20100266691 Agents and Methods to Stimulate Bone Healing
10/21/2010US20100266686 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/21/2010US20100266680 Treatment of Cancer Using TLR3 Agonists
10/21/2010US20100266677 Nucleic acid binding compounds and methods of use
10/21/2010US20100266675 Lipoproteins, lipopeptides and analogs, and methods for making and using them
10/21/2010US20100266674 L-oddc prodrugs for cancer
10/21/2010US20100266673 Compositions and methods for the delivery of nitric oxide
10/21/2010US20100266668 Manufacturing Dissolvable Dosage Forms
10/21/2010US20100266661 Osteogenic implants with combined implant materials and methods for same
10/21/2010US20100266659 Implantable devices formed on non-fouling methacrylate or acrylate polymers
10/21/2010US20100266658 Osteogenic Implants with Combined Implant Materials and Methods for Same
10/21/2010US20100266654 Medical composition including an extracellular matrix particulate
10/21/2010US20100266643 Pulmonary and nasal delivery of serum amyloid p
10/21/2010US20100266639 Expression system
10/21/2010US20100266619 Neutralizing Antibodies and Methods of Use Thereof
10/21/2010US20100266618 Compositions and methods for augmenting activity of oncolytic viruses
10/21/2010US20100266615 D1-1 nucleic acids, polypeptides and related methods
10/21/2010US20100266612 Bmp-alk3 antagonists and uses for promoting bone growth
10/21/2010US20100266602 Method for Diagnosing Rheumatoid Arthritis via Assaying Myofibroblast-Like Synoviocytes for Fibroblast Activation Protein
10/21/2010US20100266601 Antibodies that inhibit tslp activity
10/21/2010US20100266599 Human receptor proteins; related reagents and methods
10/21/2010US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
10/21/2010US20100266597 Cytokine receptor zcytor17 multimers
10/21/2010US20100266581 Compositions and methods for modulating s-nitrosogluthione reductase
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266578 Treatment and diagnostic methods for hypersensitive disorders
10/21/2010US20100266577 Method of Cancer Treatment with Antagonists of FAS Inhibitors
10/21/2010US20100266572 Treatment and prevention of ischemic injury using activated protein c
10/21/2010US20100266571 Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
10/21/2010US20100266570 Dimeric derivatives of artemisinin and application in anticancer therapy
10/21/2010US20100266569 Prostatic acid phosphatase for the treatment of pain
10/21/2010US20100266568 Ec sod and use thereof
10/21/2010US20100266567 Use of urate oxidase for the treatment or prophylaxis of disorders or indirect sequelae of the heart caused by ischemic or reperfusion events
10/21/2010US20100266566 Treatments involving glutaredoxins and similar agents
10/21/2010US20100266565 Combinational Chemotherapy Treatment
10/21/2010US20100266564 Polyunsaturated Fatty Acid Synthase Nucleic Acid Molecules and Polypeptides, Compositions, and Methods of Making and Uses Thereof
10/21/2010US20100266557 Novel peptide-based scaffolds for cartilage regeneration and methods for their use
10/21/2010US20100266548 LPS-Responsive CHS1/Beige-Like Anchor Gene and Therapeutic Applications Thereof
10/21/2010US20100266547 Methods and compositions for treatment of interferon-resistant tumors
10/21/2010US20100266544 Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability
10/21/2010US20100266543 Linked dibenzimidazole antivirals
10/21/2010US20100266542 Receptor coupling agents and therapeutic uses thereof
10/21/2010US20100266541 Methods and agents for modulating an immune response
10/21/2010US20100266540 Drug class for the treatment of cancer
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266538 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/21/2010US20100266537 Hcv inhibitors
10/21/2010US20100266536 new type of consensus interferon and preparation method thereof
10/21/2010US20100266535 Compounds Having CRTH2 Antagonist Activity
10/21/2010US20100266534 Human Lymphocyte Vaccine Adjuvant
10/21/2010US20100266533 Death Domain Containing Receptors
10/21/2010US20100266532 Methods for inhibiting scarring
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266530 FcRN ANTIBODIES AND USES THEREOF
10/21/2010US20100266529 Using granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine mutein as therapeutic in treatment of neutropenia
10/21/2010US20100266528 Systemic Administration of Colony Stimulating Factors to Treat Amyloid Associated Disorders
10/21/2010US20100266499 Cytokine receptor zcytor17 multimers
10/21/2010US20100266498 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
10/21/2010US20100266496 Anti-CD74 Immunoconjugates and Methods of Use
10/21/2010US20100266492 Compounds for intracellular delivery of therapeutic moieties to nerve cells
10/21/2010US20100266491 System for targeted delivery of therapeutic agents
10/21/2010DE202010010638U1 Nano-Hydrogele für die therapeutische und nichttherapeutische Behandlung, insbesondere zur Therapie von Stresszuständen und Regeneration Nano-hydrogels for the therapeutic and non-therapeutic treatment, in particular for the treatment of stress conditions and regeneration
10/21/2010DE102009017908A1 Vektor für den Transport von mikrobiologischen Organismen zu Krankheitsherden Vector for the transport of microbiological organisms to disease sites
10/21/2010CA2759013A1 Combination immunotherapy compositions against cancer and methods
10/21/2010CA2758542A1 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
10/21/2010CA2758522A1 Novel peptide-based scaffolds for cartilage regeneration and methods for their use
10/21/2010CA2758257A1 Enzyme delivery systems and methods of preparation and use
10/21/2010CA2758229A1 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
10/21/2010CA2757711A1 Microrna as a biomarker of pancreatic islet beta-cell engagement
10/21/2010CA2757351A1 Anti-mental fatigue drug
10/21/2010CA2757289A1 Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
10/21/2010CA2757036A1 Methionine sulfoxide peptide, compositions and methods of use
10/21/2010CA2756570A1 Peptide ligands for clusterin and uses thereof
10/21/2010CA2756249A1 Muscle function enhancing peptide
10/20/2010EP2241625A1 Proteinase K resistant surface protein of neisseria meningitidis
10/20/2010EP2241623A2 Monoclonal antibody against a human cytokine receptor
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241575A1 Methods of treating obesity with combination therapeautics of igf-1 fusion polypeptides
10/20/2010EP2241564A1 3,8-diaminotetrahydroquinoline derivative
10/20/2010EP2241330A1 Contraceptive methods and compositions related to proteasomal interference
10/20/2010EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
10/20/2010EP2241328A1 Interleukin-1 inhibitors in the treatment of diseases
10/20/2010EP2241327A1 Mixtures of Amylin and Insulin
10/20/2010EP2241326A1 Pharmaceutical compositions and methods for insulin treatment
10/20/2010EP2241325A1 Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
10/20/2010EP2241324A1 Composition for use in a method for treating cancer.
10/20/2010EP2241323A1 Tenascin-W and brain cancers
10/20/2010EP2241308A2 Method for coating fine particle with lipid membrane
10/20/2010EP2240771A2 Methods and compositions for non-covalently enhanced receptor binding
10/20/2010EP2240513A2 Crystalline structure of the cc2-lz domain of nemo
1 ... 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 ... 3163